{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:54:10Z","timestamp":1786982050097,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,3,26]],"date-time":"2018-03-26T00:00:00Z","timestamp":1522022400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s11739-018-1835-9","type":"journal-article","created":{"date-parts":[[2018,3,26]],"date-time":"2018-03-26T00:54:32Z","timestamp":1522025672000},"page":"651-660","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study"],"prefix":"10.1007","volume":"13","author":[{"name":"ARAPACIS Study Collaborators","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Raparelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Pastori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena Francesca","family":"Pignataro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Rita","family":"Vestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Pignatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Cangemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Proietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Dav\u00ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William Robert","family":"Hiatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Yoke Hong","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gino Roberto","family":"Corazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Perticone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Violi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Basili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,26]]},"reference":[{"key":"1835_CR1","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1164\/rccm.201204-0596PP","volume":"187","author":"J Vestbo","year":"2013","unstructured":"Vestbo J, Hurd SS, Agusti AG et al (2013) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 187:347\u2013365","journal-title":"Am J Respir Crit Care Med"},{"key":"1835_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1183\/09031936.00138606","volume":"29","author":"J Bousquet","year":"2007","unstructured":"Bousquet J, Dahl R, Khaltaev N (2007) Global alliance against chronic respiratory diseases. Eur Respir J 29:233\u2013239","journal-title":"Eur Respir J"},{"key":"1835_CR3","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s11739-017-1690-0","volume":"12","author":"P Ambrosino","year":"2017","unstructured":"Ambrosino P, Lupoli R, Iervolino S, De Felice A, Pappone N, Storino A, Di Minno MND (2017) Clinical assessment of endothelial function in patients with chronic obstructive pulmonary disease: a systematic review with meta-analysis. Intern Emerg Med 12:877\u2013885","journal-title":"Intern Emerg Med"},{"key":"1835_CR4","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s11739-013-0945-7","volume":"9","author":"J Diez-Manglano","year":"2014","unstructured":"Diez-Manglano J, Barquero-Romero J, Almagro P et al (2014) COPD patients with and without metabolic syndrome: clinical and functional differences. Intern Emerg Med 9:419\u2013425","journal-title":"Intern Emerg Med"},{"key":"1835_CR5","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1164\/rccm.201604-0690SO","volume":"194","author":"S Roversi","year":"2016","unstructured":"Roversi S, Fabbri LM, Sin DD, Hawkins NM, Agusti A (2016) Chronic obstructive pulmonary disease and cardiac diseases: an urgent need for integrated care. Am J Respir Crit Care Med 194:1319\u20131336","journal-title":"Am J Respir Crit Care Med"},{"key":"1835_CR6","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1183\/09059180.00008612","volume":"22","author":"A Cavailles","year":"2013","unstructured":"Cavailles A, Brinchault-Rabin G, Dixmier A et al (2013) Comorbidities of COPD. Eur Respir Rev 22:454\u2013475","journal-title":"Eur Respir Rev"},{"key":"1835_CR7","doi-asserted-by":"publisher","first-page":"5861","DOI":"10.1073\/pnas.83.16.5861","volume":"83","author":"F Catella","year":"1986","unstructured":"Catella F, Healy D, Lawson JA, FitzGerald GA (1986) 11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation. Proc Natl Acad Sci USA 83:5861\u20135865","journal-title":"Proc Natl Acad Sci USA"},{"key":"1835_CR8","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1164\/ajrccm.156.6.9706026","volume":"156","author":"G Davi","year":"1997","unstructured":"Davi G, Basili S, Vieri M et al (1997) Enhanced thromboxane biosynthesis in patients with chronic obstructive pulmonary disease. The Chronic Obstructive Bronchitis and Haemostasis Study Group. Am J Respir Crit Care Med 156:1794\u20131799","journal-title":"Am J Respir Crit Care Med"},{"key":"1835_CR9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1001\/jamainternmed.2013.11912","volume":"174","author":"EZ Soliman","year":"2014","unstructured":"Soliman EZ, Safford MM, Muntner P et al (2014) Atrial fibrillation and the risk of myocardial infarction. JAMA Internal Med 174:107\u2013114","journal-title":"JAMA Internal Med"},{"key":"1835_CR10","doi-asserted-by":"publisher","first-page":"e003347","DOI":"10.1161\/JAHA.116.003347","volume":"5","author":"F Violi","year":"2016","unstructured":"Violi F, Soliman EZ, Pignatelli P, Pastori D (2016) Atrial fibrillation and myocardial infarction: a systematic review and appraisal of pathophysiologic mechanisms. J Am Heart Assoc 5:e003347","journal-title":"J Am Heart Assoc"},{"key":"1835_CR11","doi-asserted-by":"publisher","first-page":"e002197","DOI":"10.1161\/JAHA.115.002197","volume":"5","author":"SD Pokorney","year":"2016","unstructured":"Pokorney SD, Piccini JP, Stevens SR et al (2016) Cause of death and predictors of all-cause mortality in anticoagulated patients with nonvalvular atrial fibrillation: data from ROCKET AF. J Am Heart Assoc 5:e002197","journal-title":"J Am Heart Assoc"},{"key":"1835_CR12","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ijcard.2015.09.062","volume":"202","author":"MT Durheim","year":"2016","unstructured":"Durheim MT, Cyr DD, Lopes RD et al (2016) Chronic obstructive pulmonary disease in patients with atrial fibrillation: insights from the ARISTOTLE trial. Int J Cardiol 202:589\u2013594","journal-title":"Int J Cardiol"},{"key":"1835_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ahj.2016.08.011","volume":"181","author":"M Proietti","year":"2016","unstructured":"Proietti M, Laroche C, Drozd M et al (2016) Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: a report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry. Am Heart J 181:83\u201391","journal-title":"Am Heart J"},{"key":"1835_CR14","first-page":"115","volume-title":"Ankle-Brachial Index and cardiovascular events in atrial fibrillation","author":"F Violi","year":"2016","unstructured":"Violi F, Davi G, Proietti M et al (2016) Ankle-Brachial Index and cardiovascular events in atrial fibrillation. The ARAPACIS Study, Thromb Haemost, p 115"},{"key":"1835_CR15","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/j.jacc.2013.07.035","volume":"62","author":"F Violi","year":"2013","unstructured":"Violi F, Davi G, Hiatt W et al (2013) Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy. J Am Coll Cardiol 62:2255\u20132256","journal-title":"J Am Coll Cardiol"},{"key":"1835_CR16","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s11739-014-1096-1","volume":"9","author":"V Raparelli","year":"2014","unstructured":"Raparelli V, Proietti M, Butta C et al (2014) Medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study. Intern Emerg Med 9:861\u2013870","journal-title":"Intern Emerg Med"},{"key":"1835_CR17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GY Lip","year":"2010","unstructured":"Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137:263\u2013272","journal-title":"Chest"},{"key":"1835_CR18","unstructured":"Kirchhof P, Benussi S, Kotecha D et al (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC)Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESCEndorsed by the European Stroke Organisation (ESO). European heart journal"},{"key":"1835_CR19","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1161\/CIRCULATIONAHA.107.187397","volume":"116","author":"K Thygesen","year":"2007","unstructured":"Thygesen K, Alpert JS, White HD et al (2007) Universal definition of myocardial infarction. Circulation 116:2634\u20132653","journal-title":"Circulation"},{"key":"1835_CR20","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1161\/01.STR.21.5.707","volume":"21","author":"JP Whisnant","year":"1990","unstructured":"Whisnant JP, Basford JR, Bernstein EF et al. (1990) Classification of cerebrovascular diseases III. Stroke 21:637\u2013676","journal-title":"Stroke"},{"key":"1835_CR21","doi-asserted-by":"publisher","DOI":"10.1201\/9781420035933","volume-title":"Subset selection in regression. CRC monographs on statistics and applied probability","author":"AJ Miller","year":"2002","unstructured":"Miller AJ (2002) Subset selection in regression. CRC monographs on statistics and applied probability. Chapman & Hall, CRC Press"},{"key":"1835_CR22","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ijcard.2015.08.054","volume":"201","author":"D Pastori","year":"2015","unstructured":"Pastori D, Pignatelli P, Saliola M et al (2015) Inadequate anticoagulation by vitamin K Antagonists is associated with major adverse cardiovascular events in patients with atrial fibrillation. Int J Cardiol 201:513\u2013516","journal-title":"Int J Cardiol"},{"issue":"490\u2013497","key":"1835_CR23","first-page":"e491","volume":"170","author":"D Pastori","year":"2015","unstructured":"Pastori D, Pignatelli P, Farcomeni A et al (2015) Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in patients with atrial fibrillation. Am Heart J 170(490\u2013497):e491","journal-title":"Am Heart J"},{"key":"1835_CR24","doi-asserted-by":"publisher","first-page":"39143","DOI":"10.18632\/oncotarget.9826","volume":"7","author":"D Pastori","year":"2016","unstructured":"Pastori D, Pignatelli P, Farcomeni A, Nocella C, Bartimoccia S, Carnevale R, Violi F (2016) Age-related increase of thromboxane B2 and risk of cardiovascular disease in atrial fibrillation. Oncotarget 7:39143\u201339147","journal-title":"Oncotarget"},{"key":"1835_CR25","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1378\/chest.14-2414","volume":"147","author":"D Pastori","year":"2015","unstructured":"Pastori D, Pignatelli P, Angelico F et al (2015) Incidence of myocardial infarction and vascular death in elderly patients with atrial fibrillation taking anticoagulants: relation to atherosclerotic risk factors. Chest 147:1644\u20131650","journal-title":"Chest"},{"key":"1835_CR26","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1093\/eurheartj\/ehv466","volume":"37","author":"AJ Camm","year":"2015","unstructured":"Camm AJ, Amarenco P, Haas S et al (2015) XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation. Eur Heart J 37:1145\u20134453","journal-title":"Eur Heart J"},{"key":"1835_CR27","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1378\/chest.14-2414","volume":"147","author":"D Pastori","year":"2015","unstructured":"Pastori D, Pignatelli P, Angelico F et al (2015) Incidence of myocardial infarction and vascular death in elderly patients with atrial fibrillation taking anticoagulants: relation to atherosclerotic risk factors. Chest 147:1644\u20131650","journal-title":"Chest"},{"issue":"329\u2013336","key":"1835_CR28","first-page":"e324","volume":"127","author":"TB Larsen","year":"2014","unstructured":"Larsen TB, Rasmussen LH, Gorst-Rasmussen A, Skjoth F, Rosenzweig M, Lane DA, Lip GY (2014) Myocardial ischemic events in \u2018real world\u2019 patients with atrial fibrillation treated with dabigatran or warfarin. Am J Med 127(329\u2013336):e324","journal-title":"Am J Med"},{"key":"1835_CR29","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3109\/09537109409006435","volume":"5","author":"P Ferroni","year":"1994","unstructured":"Ferroni P, Basili S, Pulcinelli FM, Pettirossi G, Alessandri C, Violi F, Gazzaniga PP, Cordova C (1994) In vivo thrombin generation and platelet hyperactivity in patients with chronic obstructive pulmonary disease. Platelets 5:276\u2013278","journal-title":"Platelets"},{"key":"1835_CR30","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1586\/17474086.2013.814835","volume":"6","author":"M Malerba","year":"2013","unstructured":"Malerba M, Clini E, Malagola M, Avanzi GC (2013) Platelet activation as a novel mechanism of atherothrombotic risk in chronic obstructive pulmonary disease. Expert Rev Hematol 6:475\u2013483","journal-title":"Expert Rev Hematol"},{"key":"1835_CR31","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1007\/s00392-016-0999-4","volume":"105","author":"M Proietti","year":"2016","unstructured":"Proietti M, Nobili A, Raparelli V, Napoleone L, Mannucci PM, Lip GY, Investigators R (2016) Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study. Clin Res Cardiol 105:912\u2013920","journal-title":"Clin Res Cardiol"},{"key":"1835_CR32","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.phrs.2016.09.035","volume":"113","author":"P Pignatelli","year":"2016","unstructured":"Pignatelli P, Pastori D, Bartimoccia S, Menichelli D, Vicario T, Nocella C, Carnevale R, Violi F (2016) Anti Xa oral anticoagulants inhibit in vivo platelet activation by modulating glycoprotein VI shedding. Pharmacol Res 113:484\u2013489","journal-title":"Pharmacol Res"},{"key":"1835_CR33","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1161\/CIRCRESAHA.117.312144","volume":"122","author":"JA Mitchell","year":"2018","unstructured":"Mitchell JA, Knowles RB, Kirkby NS et al (2018) Kidney transplantation in a patient lacking cytosolic phospholipase A2 Proves Renal Origins of urinary PGI-M and TX-M. Circ Res 122:555\u2013559","journal-title":"Circ Res"},{"key":"1835_CR34","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1161\/CIRCRESAHA.118.312616","volume":"122","author":"T Grosser","year":"2018","unstructured":"Grosser T, Naji A, FitzGerald GA (2018) Urinary prostaglandin metabolites: an incomplete reckoning and a flush to judgment. Circ Res 122:537\u2013539","journal-title":"Circ Res"}],"updated-by":[{"DOI":"10.1007\/s11739-018-1922-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T00:00:00Z","timestamp":1533254400000}}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11739-018-1835-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-018-1835-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-018-1835-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T18:04:33Z","timestamp":1555437873000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11739-018-1835-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,26]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["1835"],"URL":"https:\/\/doi.org\/10.1007\/s11739-018-1835-9","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,26]]},"assertion":[{"value":"20 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2018","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the original publication, one of the ARAPACIS collaborators Dr. \u201cLeonardo Di Gennaro\u201d name has been erroneously mentioned as \u201cLeonardo De Gennaro\u201d.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study involving human participants were in accordance with the ethical standard of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human and animal rights"}},{"value":"Informed consent was obtained from all individual participants included in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}